UNSPSC 51282940: Premafloxacin

This classification denotes a quinolone antibiotic with the molecular formula C21H26FN3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UOM2HMO524, chemically known as 3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-(1-(methylamino)ethyl)-1-pyrrolidinyl)-4-oxo-, (s-(r*,s*))- but generally known as premafloxacin, which bears US NIH Compound Identifier 71455. European Medicines Agency schedules Premafloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10025MIG.

UNSPSC 51282940 Premafloxacin is a Commodity code representing specific pharmaceutical products state and local health agencies and departments procure, though recent posted opportunities show substantial mismatch with the code's nominal scope. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical contract through the MMCAP Infuse consortium to Chartwell Rx LLC covering Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets, not premafloxacin, with an initial 12-month term and two optional renewal years. Seminole County, Florida posted an IFB for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries and a two-year initial term plus one-year renewal option. The code is being used to tag pharmaceutical and medical supply orders placed by state departments of health and county health authorities.

The code shows recent activity concentrated in Florida and Illinois. The Illinois award to Chartwell Rx LLC was completed under an IFB process with response deadline September 11, 2026. Seminole County's naloxone and drug deactivation system procurement was posted June 30, 2026 with a July 26, 2023 response deadline, suggesting outdated listing metadata or a retrospective posting. However, the preponderance of recent opportunities tagged to this code involve antibiotics and emergency medical supplies rather than premafloxacin specifically, indicating either inconsistent code assignment by issuing bodies or the code serving as a catch-all for antibiotic and pharmaceutical inventory purchases across state and local health procurement. Vendors should verify actual product requirements in bid documents rather than relying on code naming alone.